The bottom line : Your taste buds regenerate every couple of weeksbut your ever-changing mind and personal experiences have more to do with why you might start to like or dislike a new food.
A conceptual model of food cue reactivity, Nutrients (2023) Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) Your guide to FDA-approved medicines that contain semaglutide, Novo Nordisk FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food & Drug Administration (2024) Wegovy, DailyMed (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) OFA v
Metabolic Rebound and Appetite Dysregulation After Stopping Your metabolism doesn't simply return to its pre-treatment baselineit often overshoots into a hyperappetitive state
The STEP-1 trial tested the effect of high-dose semaglutide to produce weight loss in people with obesity who do not have diabetes
Natalie Louise Burrows, Nutritional Therapist and Clinic Director of Integral Wellness, takes a look at whether GLP-1 supplements could bring the same results in a more natural, holistic health way
